(HLN) Haleon - Performance 25.7% in 12m
Compare HLN with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
51.77%
#10 in Group
Rel. Strength
81.76%
#1458 in Universe
Total Return 12m
25.68%
#35 in Group
Total Return 5y
43.67%
#29 in Group
P/E 24.7
59th Percentile in Group
P/E Forward 20.3
71th Percentile in Group
PEG 1.80
88th Percentile in Group
FCF Yield 4.88%
89th Percentile in Group
12m Total Return: HLN (25.7%) vs XBI (-7.2%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8.45% | 25.1% | 163% | 11.8 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
3.06% | 25.7% | 43.7% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-11.4% | 5.51% | 37.4% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
-3.34% | 9.2% | 33.3% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-3.25% | 13.2% | -1.03% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
NBIX NASDAQ Neurocrine Biosciences |
-12% | -23.9% | 3.63% | 30.8 | 20.4 | 0.27 | 61.5% | 31.6% |
KMDA NASDAQ Kamada |
-8.87% | 30.5% | -10.1% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
-2.43% | -17.2% | 17.1% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
Performance Comparison: HLN vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for HLN
Total Return (including Dividends) | HLN | XBI | S&P 500 |
---|---|---|---|
1 Month | 3.06% | -12.59% | -8.16% |
3 Months | 13.34% | -14.87% | -12.80% |
12 Months | 25.68% | -7.16% | 6.85% |
5 Years | 43.67% | -19.64% | 100.40% |
Trend Score (consistency of price movement) | HLN | XBI | S&P 500 |
1 Month | 18.8% | -52.8% | -63.5% |
3 Months | 47.2% | -92.8% | -90.3% |
12 Months | 60.9% | -32.4% | 60.6% |
5 Years | 88.5% | -53.3% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #38 | 17.9% | 12.2% |
3 Month | #18 | 33.1% | 30.0% |
12 Month | #35 | 35.4% | 17.6% |
5 Years | #35 | 47.3% | 0.04% |
FAQs
Does HLN Haleon outperforms the market?
Yes,
over the last 12 months HLN made 25.68%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.16%.
Over the last 3 months HLN made 13.34%, while XBI made -14.87%.
Over the last 3 months HLN made 13.34%, while XBI made -14.87%.
Performance Comparison HLN vs Indeces and Sectors
HLN vs. Indices HLN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 5.19% | 11.2% | 14.5% | 18.8% |
US NASDAQ 100 | QQQ | 6.21% | 12.5% | 15.6% | 18.9% |
US Dow Jones Industrial 30 | DIA | 6.14% | 10.9% | 13.5% | 21.5% |
German DAX 40 | DAX | 3.10% | 9.92% | -3.97% | 7.17% |
Shanghai Shenzhen CSI 300 | CSI 300 | 1.57% | 6.79% | 12.1% | 17.6% |
Hongkong Hang Seng | HSI | 0.14% | 8.02% | 9.85% | 8.41% |
India NIFTY 50 | INDA | -1.38% | 0.41% | 8.51% | 21.8% |
Brasil Bovespa | EWZ | -0.76% | 4.32% | 9.16% | 35.6% |
HLN vs. Sectors HLN is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 5.03% | 11.4% | 5.47% | 10.7% |
Consumer Discretionary | XLY | 4.71% | 11.9% | 10.6% | 15.5% |
Consumer Staples | XLP | 1.77% | -0.52% | 3.87% | 13.4% |
Energy | XLE | 0.30% | 15.4% | 13.8% | 37.7% |
Financial | XLF | 3.49% | 9.02% | 4.64% | 8.49% |
Health Care | XLV | 5.17% | 11.3% | 15.3% | 27.3% |
Industrial | XLI | 4.62% | 10.3% | 13.8% | 21.5% |
Materials | XLB | 2.58% | 9.02% | 19.8% | 32.5% |
Real Estate | XLRE | 1.80% | 6.41% | 11.8% | 10.1% |
Technology | XLK | 7.46% | 14.6% | 22.1% | 25.9% |
Utilities | XLU | 2.85% | 3.28% | 8.08% | 3.94% |
Aerospace & Defense | XAR | 5.55% | 8.43% | 5.69% | 4.50% |
Biotech | XBI | 1.82% | 15.7% | 26.4% | 32.8% |
Homebuilder | XHB | 2.06% | 11.0% | 27.2% | 33.7% |
Retail | XRT | 0.98% | 8.68% | 16.4% | 30.1% |